The global Neonatal Respiratory Distress Syndrome Treatment market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Oxygen Therapy Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Neonatal Respiratory Distress Syndrome Treatment include Medtronic, Dragerwerk, GE HealthCare, Koninklijke Philips, Smiths Medical, Fisher & Paykel Healthcare, IBIO, Windtree Therapeutics and Synthetic Biologics, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Neonatal Respiratory Distress Syndrome Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neonatal Respiratory Distress Syndrome Treatment. This report contains market size and forecasts of Neonatal Respiratory Distress Syndrome Treatment in global, including the following market information:
Global Neonatal Respiratory Distress Syndrome Treatment Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Neonatal Respiratory Distress Syndrome Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neonatal Respiratory Distress Syndrome Treatment Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Neonatal Respiratory Distress Syndrome Treatment Market Segment Percentages, by Type, 2023 (%)
Oxygen Therapy
Surfactant Therapy
Others
Global Neonatal Respiratory Distress Syndrome Treatment Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Neonatal Respiratory Distress Syndrome Treatment Market Segment Percentages, by Application, 2023 (%)
Hospitals
Home Care
Others
Global Neonatal Respiratory Distress Syndrome Treatment Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Neonatal Respiratory Distress Syndrome Treatment Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Neonatal Respiratory Distress Syndrome Treatment revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Neonatal Respiratory Distress Syndrome Treatment revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
Dragerwerk
GE HealthCare
Koninklijke Philips
Smiths Medical
Fisher & Paykel Healthcare
IBIO
Windtree Therapeutics
Synthetic Biologics
Synairgen
Outline of Major Chapters:
Chapter 1: Introduces the definition of Neonatal Respiratory Distress Syndrome Treatment, market overview.
Chapter 2: Global Neonatal Respiratory Distress Syndrome Treatment market size in revenue.
Chapter 3: Detailed analysis of Neonatal Respiratory Distress Syndrome Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Neonatal Respiratory Distress Syndrome Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Neonatal Respiratory Distress Syndrome Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neonatal Respiratory Distress Syndrome Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neonatal Respiratory Distress Syndrome Treatment Overall Market Size
2.1 Global Neonatal Respiratory Distress Syndrome Treatment Market Size: 2023 VS 2030
2.2 Global Neonatal Respiratory Distress Syndrome Treatment Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Neonatal Respiratory Distress Syndrome Treatment Players in Global Market
3.2 Top Global Neonatal Respiratory Distress Syndrome Treatment Companies Ranked by Revenue
3.3 Global Neonatal Respiratory Distress Syndrome Treatment Revenue by Companies
3.4 Top 3 and Top 5 Neonatal Respiratory Distress Syndrome Treatment Companies in Global Market, by Revenue in 2023
3.5 Global Companies Neonatal Respiratory Distress Syndrome Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neonatal Respiratory Distress Syndrome Treatment Players in Global Market
3.6.1 List of Global Tier 1 Neonatal Respiratory Distress Syndrome Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Neonatal Respiratory Distress Syndrome Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Neonatal Respiratory Distress Syndrome Treatment Market Size Markets, 2023 & 2030
4.1.2 Oxygen Therapy
4.1.3 Surfactant Therapy
4.1.4 Others
4.2 By Type - Global Neonatal Respiratory Distress Syndrome Treatment Revenue & Forecasts
4.2.1 By Type - Global Neonatal Respiratory Distress Syndrome Treatment Revenue, 2019-2024
4.2.2 By Type - Global Neonatal Respiratory Distress Syndrome Treatment Revenue, 2025-2030
4.2.3 By Type - Global Neonatal Respiratory Distress Syndrome Treatment Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Neonatal Respiratory Distress Syndrome Treatment Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Home Care
5.1.4 Others
5.2 By Application - Global Neonatal Respiratory Distress Syndrome Treatment Revenue & Forecasts
5.2.1 By Application - Global Neonatal Respiratory Distress Syndrome Treatment Revenue, 2019-2024
5.2.2 By Application - Global Neonatal Respiratory Distress Syndrome Treatment Revenue, 2025-2030
5.2.3 By Application - Global Neonatal Respiratory Distress Syndrome Treatment Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Neonatal Respiratory Distress Syndrome Treatment Market Size, 2023 & 2030
6.2 By Region - Global Neonatal Respiratory Distress Syndrome Treatment Revenue & Forecasts
6.2.1 By Region - Global Neonatal Respiratory Distress Syndrome Treatment Revenue, 2019-2024
6.2.2 By Region - Global Neonatal Respiratory Distress Syndrome Treatment Revenue, 2025-2030
6.2.3 By Region - Global Neonatal Respiratory Distress Syndrome Treatment Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Neonatal Respiratory Distress Syndrome Treatment Revenue, 2019-2030
6.3.2 US Neonatal Respiratory Distress Syndrome Treatment Market Size, 2019-2030
6.3.3 Canada Neonatal Respiratory Distress Syndrome Treatment Market Size, 2019-2030
6.3.4 Mexico Neonatal Respiratory Distress Syndrome Treatment Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Neonatal Respiratory Distress Syndrome Treatment Revenue, 2019-2030
6.4.2 Germany Neonatal Respiratory Distress Syndrome Treatment Market Size, 2019-2030
6.4.3 France Neonatal Respiratory Distress Syndrome Treatment Market Size, 2019-2030
6.4.4 U.K. Neonatal Respiratory Distress Syndrome Treatment Market Size, 2019-2030
6.4.5 Italy Neonatal Respiratory Distress Syndrome Treatment Market Size, 2019-2030
6.4.6 Russia Neonatal Respiratory Distress Syndrome Treatment Market Size, 2019-2030
6.4.7 Nordic Countries Neonatal Respiratory Distress Syndrome Treatment Market Size, 2019-2030
6.4.8 Benelux Neonatal Respiratory Distress Syndrome Treatment Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Neonatal Respiratory Distress Syndrome Treatment Revenue, 2019-2030
6.5.2 China Neonatal Respiratory Distress Syndrome Treatment Market Size, 2019-2030
6.5.3 Japan Neonatal Respiratory Distress Syndrome Treatment Market Size, 2019-2030
6.5.4 South Korea Neonatal Respiratory Distress Syndrome Treatment Market Size, 2019-2030
6.5.5 Southeast Asia Neonatal Respiratory Distress Syndrome Treatment Market Size, 2019-2030
6.5.6 India Neonatal Respiratory Distress Syndrome Treatment Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Neonatal Respiratory Distress Syndrome Treatment Revenue, 2019-2030
6.6.2 Brazil Neonatal Respiratory Distress Syndrome Treatment Market Size, 2019-2030
6.6.3 Argentina Neonatal Respiratory Distress Syndrome Treatment Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Revenue, 2019-2030
6.7.2 Turkey Neonatal Respiratory Distress Syndrome Treatment Market Size, 2019-2030
6.7.3 Israel Neonatal Respiratory Distress Syndrome Treatment Market Size, 2019-2030
6.7.4 Saudi Arabia Neonatal Respiratory Distress Syndrome Treatment Market Size, 2019-2030
6.7.5 UAE Neonatal Respiratory Distress Syndrome Treatment Market Size, 2019-2030
7 Neonatal Respiratory Distress Syndrome Treatment Companies Profiles
7.1 Medtronic
7.1.1 Medtronic Company Summary
7.1.2 Medtronic Business Overview
7.1.3 Medtronic Neonatal Respiratory Distress Syndrome Treatment Major Product Offerings
7.1.4 Medtronic Neonatal Respiratory Distress Syndrome Treatment Revenue in Global Market (2019-2024)
7.1.5 Medtronic Key News & Latest Developments
7.2 Dragerwerk
7.2.1 Dragerwerk Company Summary
7.2.2 Dragerwerk Business Overview
7.2.3 Dragerwerk Neonatal Respiratory Distress Syndrome Treatment Major Product Offerings
7.2.4 Dragerwerk Neonatal Respiratory Distress Syndrome Treatment Revenue in Global Market (2019-2024)
7.2.5 Dragerwerk Key News & Latest Developments
7.3 GE HealthCare
7.3.1 GE HealthCare Company Summary
7.3.2 GE HealthCare Business Overview
7.3.3 GE HealthCare Neonatal Respiratory Distress Syndrome Treatment Major Product Offerings
7.3.4 GE HealthCare Neonatal Respiratory Distress Syndrome Treatment Revenue in Global Market (2019-2024)
7.3.5 GE HealthCare Key News & Latest Developments
7.4 Koninklijke Philips
7.4.1 Koninklijke Philips Company Summary
7.4.2 Koninklijke Philips Business Overview
7.4.3 Koninklijke Philips Neonatal Respiratory Distress Syndrome Treatment Major Product Offerings
7.4.4 Koninklijke Philips Neonatal Respiratory Distress Syndrome Treatment Revenue in Global Market (2019-2024)
7.4.5 Koninklijke Philips Key News & Latest Developments
7.5 Smiths Medical
7.5.1 Smiths Medical Company Summary
7.5.2 Smiths Medical Business Overview
7.5.3 Smiths Medical Neonatal Respiratory Distress Syndrome Treatment Major Product Offerings
7.5.4 Smiths Medical Neonatal Respiratory Distress Syndrome Treatment Revenue in Global Market (2019-2024)
7.5.5 Smiths Medical Key News & Latest Developments
7.6 Fisher & Paykel Healthcare
7.6.1 Fisher & Paykel Healthcare Company Summary
7.6.2 Fisher & Paykel Healthcare Business Overview
7.6.3 Fisher & Paykel Healthcare Neonatal Respiratory Distress Syndrome Treatment Major Product Offerings
7.6.4 Fisher & Paykel Healthcare Neonatal Respiratory Distress Syndrome Treatment Revenue in Global Market (2019-2024)
7.6.5 Fisher & Paykel Healthcare Key News & Latest Developments
7.7 IBIO
7.7.1 IBIO Company Summary
7.7.2 IBIO Business Overview
7.7.3 IBIO Neonatal Respiratory Distress Syndrome Treatment Major Product Offerings
7.7.4 IBIO Neonatal Respiratory Distress Syndrome Treatment Revenue in Global Market (2019-2024)
7.7.5 IBIO Key News & Latest Developments
7.8 Windtree Therapeutics
7.8.1 Windtree Therapeutics Company Summary
7.8.2 Windtree Therapeutics Business Overview
7.8.3 Windtree Therapeutics Neonatal Respiratory Distress Syndrome Treatment Major Product Offerings
7.8.4 Windtree Therapeutics Neonatal Respiratory Distress Syndrome Treatment Revenue in Global Market (2019-2024)
7.8.5 Windtree Therapeutics Key News & Latest Developments
7.9 Synthetic Biologics
7.9.1 Synthetic Biologics Company Summary
7.9.2 Synthetic Biologics Business Overview
7.9.3 Synthetic Biologics Neonatal Respiratory Distress Syndrome Treatment Major Product Offerings
7.9.4 Synthetic Biologics Neonatal Respiratory Distress Syndrome Treatment Revenue in Global Market (2019-2024)
7.9.5 Synthetic Biologics Key News & Latest Developments
7.10 Synairgen
7.10.1 Synairgen Company Summary
7.10.2 Synairgen Business Overview
7.10.3 Synairgen Neonatal Respiratory Distress Syndrome Treatment Major Product Offerings
7.10.4 Synairgen Neonatal Respiratory Distress Syndrome Treatment Revenue in Global Market (2019-2024)
7.10.5 Synairgen Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Neonatal Respiratory Distress Syndrome Treatment Market Opportunities & Trends in Global Market
Table 2. Neonatal Respiratory Distress Syndrome Treatment Market Drivers in Global Market
Table 3. Neonatal Respiratory Distress Syndrome Treatment Market Restraints in Global Market
Table 4. Key Players of Neonatal Respiratory Distress Syndrome Treatment in Global Market
Table 5. Top Neonatal Respiratory Distress Syndrome Treatment Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Neonatal Respiratory Distress Syndrome Treatment Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Neonatal Respiratory Distress Syndrome Treatment Revenue Share by Companies, 2019-2024
Table 8. Global Companies Neonatal Respiratory Distress Syndrome Treatment Product Type
Table 9. List of Global Tier 1 Neonatal Respiratory Distress Syndrome Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Neonatal Respiratory Distress Syndrome Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Neonatal Respiratory Distress Syndrome Treatment Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Neonatal Respiratory Distress Syndrome Treatment Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Neonatal Respiratory Distress Syndrome Treatment Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Neonatal Respiratory Distress Syndrome Treatment Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Neonatal Respiratory Distress Syndrome Treatment Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Neonatal Respiratory Distress Syndrome Treatment Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2025-2030
Table 30. Medtronic Company Summary
Table 31. Medtronic Neonatal Respiratory Distress Syndrome Treatment Product Offerings
Table 32. Medtronic Neonatal Respiratory Distress Syndrome Treatment Revenue (US$, Mn) & (2019-2024)
Table 33. Medtronic Key News & Latest Developments
Table 34. Dragerwerk Company Summary
Table 35. Dragerwerk Neonatal Respiratory Distress Syndrome Treatment Product Offerings
Table 36. Dragerwerk Neonatal Respiratory Distress Syndrome Treatment Revenue (US$, Mn) & (2019-2024)
Table 37. Dragerwerk Key News & Latest Developments
Table 38. GE HealthCare Company Summary
Table 39. GE HealthCare Neonatal Respiratory Distress Syndrome Treatment Product Offerings
Table 40. GE HealthCare Neonatal Respiratory Distress Syndrome Treatment Revenue (US$, Mn) & (2019-2024)
Table 41. GE HealthCare Key News & Latest Developments
Table 42. Koninklijke Philips Company Summary
Table 43. Koninklijke Philips Neonatal Respiratory Distress Syndrome Treatment Product Offerings
Table 44. Koninklijke Philips Neonatal Respiratory Distress Syndrome Treatment Revenue (US$, Mn) & (2019-2024)
Table 45. Koninklijke Philips Key News & Latest Developments
Table 46. Smiths Medical Company Summary
Table 47. Smiths Medical Neonatal Respiratory Distress Syndrome Treatment Product Offerings
Table 48. Smiths Medical Neonatal Respiratory Distress Syndrome Treatment Revenue (US$, Mn) & (2019-2024)
Table 49. Smiths Medical Key News & Latest Developments
Table 50. Fisher & Paykel Healthcare Company Summary
Table 51. Fisher & Paykel Healthcare Neonatal Respiratory Distress Syndrome Treatment Product Offerings
Table 52. Fisher & Paykel Healthcare Neonatal Respiratory Distress Syndrome Treatment Revenue (US$, Mn) & (2019-2024)
Table 53. Fisher & Paykel Healthcare Key News & Latest Developments
Table 54. IBIO Company Summary
Table 55. IBIO Neonatal Respiratory Distress Syndrome Treatment Product Offerings
Table 56. IBIO Neonatal Respiratory Distress Syndrome Treatment Revenue (US$, Mn) & (2019-2024)
Table 57. IBIO Key News & Latest Developments
Table 58. Windtree Therapeutics Company Summary
Table 59. Windtree Therapeutics Neonatal Respiratory Distress Syndrome Treatment Product Offerings
Table 60. Windtree Therapeutics Neonatal Respiratory Distress Syndrome Treatment Revenue (US$, Mn) & (2019-2024)
Table 61. Windtree Therapeutics Key News & Latest Developments
Table 62. Synthetic Biologics Company Summary
Table 63. Synthetic Biologics Neonatal Respiratory Distress Syndrome Treatment Product Offerings
Table 64. Synthetic Biologics Neonatal Respiratory Distress Syndrome Treatment Revenue (US$, Mn) & (2019-2024)
Table 65. Synthetic Biologics Key News & Latest Developments
Table 66. Synairgen Company Summary
Table 67. Synairgen Neonatal Respiratory Distress Syndrome Treatment Product Offerings
Table 68. Synairgen Neonatal Respiratory Distress Syndrome Treatment Revenue (US$, Mn) & (2019-2024)
Table 69. Synairgen Key News & Latest Developments
List of Figures
Figure 1. Neonatal Respiratory Distress Syndrome Treatment Segment by Type in 2023
Figure 2. Neonatal Respiratory Distress Syndrome Treatment Segment by Application in 2023
Figure 3. Global Neonatal Respiratory Distress Syndrome Treatment Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Neonatal Respiratory Distress Syndrome Treatment Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Neonatal Respiratory Distress Syndrome Treatment Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Neonatal Respiratory Distress Syndrome Treatment Revenue in 2023
Figure 8. By Type - Global Neonatal Respiratory Distress Syndrome Treatment Revenue Market Share, 2019-2030
Figure 9. By Application - Global Neonatal Respiratory Distress Syndrome Treatment Revenue Market Share, 2019-2030
Figure 10. By Type - Global Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Neonatal Respiratory Distress Syndrome Treatment Revenue Market Share, 2019-2030
Figure 12. By Application - Global Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Neonatal Respiratory Distress Syndrome Treatment Revenue Market Share, 2019-2030
Figure 14. By Region - Global Neonatal Respiratory Distress Syndrome Treatment Revenue Market Share, 2019-2030
Figure 15. By Country - North America Neonatal Respiratory Distress Syndrome Treatment Revenue Market Share, 2019-2030
Figure 16. US Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Neonatal Respiratory Distress Syndrome Treatment Revenue Market Share, 2019-2030
Figure 20. Germany Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 21. France Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Neonatal Respiratory Distress Syndrome Treatment Revenue Market Share, 2019-2030
Figure 28. China Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 32. India Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Neonatal Respiratory Distress Syndrome Treatment Revenue Market Share, 2019-2030
Figure 34. Brazil Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Revenue Market Share, 2019-2030
Figure 37. Turkey Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Neonatal Respiratory Distress Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 41. Medtronic Neonatal Respiratory Distress Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Dragerwerk Neonatal Respiratory Distress Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. GE HealthCare Neonatal Respiratory Distress Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Koninklijke Philips Neonatal Respiratory Distress Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Smiths Medical Neonatal Respiratory Distress Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Fisher & Paykel Healthcare Neonatal Respiratory Distress Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. IBIO Neonatal Respiratory Distress Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Windtree Therapeutics Neonatal Respiratory Distress Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Synthetic Biologics Neonatal Respiratory Distress Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Synairgen Neonatal Respiratory Distress Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
